Pharmacokinetics, Dialysability and Safety of HRS-9231 in Healthy Volunteers and in Patients With Impaired Renal Function

NCT06657560 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Contrast-Enhanced Magnetic Resonance Imaging Detection

Interventions

DRUG: HRS-9231

Sponsor

Shanghai Shengdi Pharmaceutical Co., Ltd